What factors are driving the rapid expansion of the global gastroenterology market, and how are new technologies transforming digestive healthcare?

The global gastroenterology market is undergoing rapid transformation as technological innovations, biologic therapies, and increased awareness of gastrointestinal (GI) diseases redefine diagnosis and treatment. Valued at USD 31.13 billion in 2024, the market is projected to reach USD 54.71 billion by 2034, expanding at a CAGR of 5.80% during 2025–2034.

Rising incidences of chronic GI disorders such as Crohn’s disease, ulcerative colitis, GERD, and irritable bowel syndrome (IBS), along with lifestyle changes and aging populations, are the major growth drivers. Moreover, the growing use of biologics, endoscopic devices, and tele-gastroenterology solutions is reshaping patient care worldwide.

Gastroenterology Market Overview

The gastroenterology market encompasses diagnostic and therapeutic solutions targeting diseases of the digestive tract, including the stomach, intestines, liver, pancreas, and esophagus. Modern gastroenterology now integrates precision medicine, digital endoscopy, and minimally invasive surgical techniques to enhance accuracy and patient comfort.

Key growth drivers include:

  • Increasing burden of gastrointestinal diseases globally

  • Technological advancements in endoscopic and imaging tools

  • Expanding use of biologics and biosimilars for inflammatory bowel disease (IBD)

  • Rising healthcare expenditure and awareness about early diagnosis

  • Growth of telemedicine and AI-powered diagnostic platforms

Gastroenterology Market Size and Growth Outlook

  • Market value in 2024: USD 31.13 Billion

  • Forecast value by 2034: USD 54.71 Billion

  • CAGR (2025–2034): 5.80%

The demand for gastroenterological therapeutics and devices is rising due to an increasing number of GI-related hospitalizations and advancements in minimally invasive treatment methods. Furthermore, the introduction of novel biologics and biosimilars has revolutionized the management of chronic gastrointestinal diseases.

Key Trends Shaping the Gastroenterology Market

1. Surge in Biologics and Biosimilars

The shift from conventional drugs to biologic and biosimilar therapies is revolutionizing the treatment of IBD and Crohn’s disease. Companies like AbbVie and Takeda are expanding their product portfolios with innovative monoclonal antibodies and targeted therapies.

2. Advancements in Endoscopic Technology

Next-generation AI-assisted endoscopes, capsule endoscopy, and robotic surgery systems have enhanced diagnostic accuracy and procedural safety.

3. Rising Adoption of Digital Gastroenterology

Digital tools and teleconsultations are improving accessibility and patient management, particularly in remote areas.

4. Focus on Preventive Gastroenterology

Early detection programs, non-invasive diagnostic tests, and microbiome-based research are helping to reduce disease progression.

5. Expanding Geriatric Population

As the global population ages, the incidence of acid reflux, colorectal cancer, and constipation-related disorders continues to rise, boosting market demand.

Market Breakup by Disease Type

  • Crohn’s Disease – Increasing prevalence due to genetic and environmental factors.

  • Ulcerative Colitis – Growing use of biologics and immunomodulators.

  • Gastroesophageal Reflux Disease (GERD) – Rising due to unhealthy dietary habits and obesity.

  • Irritable Bowel Syndrome (IBS) – Increasing stress and lifestyle-related cases.

  • Others – Includes celiac disease, peptic ulcer, and digestive cancers.

Market Breakup by Treatment Type

  • Devices: Endoscopes, capsule endoscopy tools, and imaging systems.

  • Therapeutics: Antacids, laxatives, antidiarrheal agents, antiemetics, and biologics.

  • Biologics/Biosimilars: Monoclonal antibodies and TNF inhibitors are revolutionizing IBD therapy.

  • Others: Nutraceuticals and probiotic formulations.

Highlights:

  • Biologics are projected to dominate the market by 2034.

  • Device innovations are driving faster and less invasive diagnostics.

Market Breakup by Route of Administration

  • Oral: Preferred for convenience and compliance.

  • Injectable: Growing use in biologic and biosimilar treatments.

  • Others: Includes topical and rectal formulations.

Market Breakup by End User

  • Hospitals: Major segment due to advanced diagnostic capabilities.

  • Specialty Clinics: Increasing adoption of outpatient endoscopy and day-care procedures.

  • Ambulatory Surgical Centers: Rapid growth in minimally invasive procedures.

  • Diagnostic Centers: Key players in early detection.

  • Research and Academic Institutes: Driving innovation in GI drug and device development.

Market Breakup by Distribution Channel

  • Hospital Pharmacies: Dominant distribution network for specialty medications.

  • Retail Pharmacies: Growing sales of OTC antacids and digestive aids.

  • Online Channels: Rapidly expanding due to digital health platforms and e-pharmacies.

Regional Insights

North America

  • Dominates the global gastroenterology market.

  • Strong presence of pharmaceutical giants like AbbVie, Johnson & Johnson, and Pfizer.

  • High prevalence of GERD and IBD cases.

Europe

  • Technological innovations and supportive healthcare policies drive growth.

  • Increasing adoption of biologic therapies in the U.K., Germany, and France.

Asia Pacific

  • Fastest-growing region due to rising healthcare infrastructure and patient awareness.

  • Countries like India, Japan, and China are expanding endoscopy and treatment facilities.

Latin America

  • Growing healthcare access in Brazil and Mexico supports market expansion.

Middle East & Africa

  • Gradual adoption of gastroenterological diagnostics and therapeutics in emerging economies.

Recent Developments in the Gastroenterology Market

  • AbbVie continues to expand its biologics portfolio with new indications for Crohn’s disease.

  • Takeda launched new IBD biologics targeting specific immune pathways.

  • Pfizer and GSK are investing heavily in microbiome-based therapeutics.

  • AI-driven endoscopic imaging systems are being adopted for faster diagnosis.

Challenges Facing the Gastroenterology Market

  • High cost of biologics and diagnostic devices limits accessibility.

  • Stringent regulatory approvals for new drugs and medical devices.

  • Limited healthcare infrastructure in low-income countries.

  • Complexity in treatment personalization due to patient variability.

Leading Companies in the Gastroenterology Market

  • Abbott

  • Johnson & Johnson Services Inc.

  • AbbVie Inc.

  • Salix Pharmaceuticals

  • GlaxoSmithKline Plc.

  • Takeda Pharmaceutical Company Limited

  • AstraZeneca plc

  • Astellas Pharma US, Inc.

  • Pfizer Inc.

These companies are leading innovation through R&D, product launches, and global partnerships.

Future Outlook

The future of the gastroenterology market lies in personalized medicine, AI diagnostics, and biologic drug development. The growing use of non-invasive procedures, along with real-time data analytics for patient monitoring, will further revolutionize digestive healthcare by 2034.

Find More Reports

Dental Equipment Market

India Vitamin Gummies Market

India Medical Gases Market

Osteoarthritis Therapeutics Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com